Skip to search formSkip to main contentSkip to account menu

succinylacetone

Known as: 4,6-dioxoheptanoic acid, Heptanoic acid, 4,6-dioxo- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
It is very rare to find reports concerning a drug therapy successively treating chromosomal abnormalities. In this paper, we are… 
2016
2016
01. Inborn errors of metabolism in adults O-001 Interim data from a randomized, placebo controlled, phase 1 study of ALN-AS1, an… 
2015
2015
BACKGROUND Hereditary tyrosinemia type 1 (HT1) is an autosomal recessive disease caused by a defect of fumarylacetoacetate… 
1998
1998
Graven, Krista K., Robert J. McDonald, and Harrison W. Farber. Hypoxic regulation of endothelial glyceraldehyde3-phosphate… 
1985
1985
Succinylacetone, a catabolic end-product of tyrosine, is excreted in large quantities in urine from individuals with hereditary… 
1984
1984
The average analytical recovery of succinylacetone added to urine and separated by capillary gas chromatography was 69% for… 
1984
1984
Succinylacetone (SA., 4,6-diketoheptanoic acid) is elevated both in the urine of patients with hereditary tyrosinaemia type 1… 
1982
1982
SA, an inhibitor of ALA dehydrase, the second enzyme of the heme biosynthetic pathway, has been shown to exert immunosuppressive… 
1982
1982
Succinylacetone, an abnormal metabolite of the tyrosine metabolic pathway, is produced in patients with hereditary tyrosinemia… 
1981
1981
Heme levels and growth of malignant murine erythroleukemia cells in heme-free medium are drastically reduced by incubation of…